Phase 1 Pyrotinib
(Monotherapy)
vs lapatinib plus capecitabine in HER2+
MBC
Xu. SABCS2017
PAN INHIBIDOR IRREVERSIBLE TK1. CON
ACTIVIDAD frente EGFR/HER21, HER2, HER4.